Enzymatica AB (publ) (STO:ENZY)
Sweden · Delayed Price · Currency is SEK 1.750
-0.010 (-0.57%)
Oct 15, 2026, 12:06 PM CET
Enzymatica AB Market Cap
Enzymatica AB has a market cap or net worth of 424.79 million as of October 14, 2026. It is the 31,430th most valuable company in the world and the 411th biggest in Sweden. Its market cap has decreased by 12.50% in one year.
Market Cap
424.79M
Enterprise Value
425.81M
Revenue
51.93M
Global Rank
Country Rank
#411 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 14, 2011, Enzymatica AB's market cap has increased from 108.93M to 424.79M, an increase of 289.97%. That is a compound annual growth rate of 9.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 424.79M | -7.89% |
| Dec 30, 2025 | 461.20M | 35.28% |
| Dec 30, 2024 | 340.92M | -47.39% |
| Dec 29, 2023 | 647.99M | -12.33% |
| Dec 30, 2022 | 739.16M | -43.36% |
| Dec 30, 2021 | 1.31B | -51.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 1.97B |
| Cereno Scientific AB | 1.18B |
| Dicot Pharma AB | 856.07M |
| EQL Pharma AB | 659.99M |
| Cinclus Pharma Holding AB | 590.10M |
| Moberg Pharma AB | 533.14M |
| Orexo AB | 225.40M |
| Klaria Pharma Holding AB (publ.) | 122.74M |